Precision Oncology Market is Estimated to grow at a CAGR of 9.8% during the forecast period
With a projected valuation of USD 98.7 billion in 2022, the
worldwide precision oncology market is
anticipated to grow at a compound annual growth rate (CAGR) of 9.8%. The main
factors driving the market are the growing effects of technology, the growing
desire to reduce the adverse effects of cancer treatments, and the need to
prevent particular medication resistance.
The market is expanding as a result of rising global
healthcare costs, growing biotechnology investment, and a growing need for
early detection of breast cancer. Growth in healthcare facilities and growing
consumer knowledge of precision oncology are major factors propelling the
market's expansion.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/precision-oncology-market
Growth Drivers
Some of the drivers propelling market expansion include
government initiatives and financing, growing awareness of precision medicine,
and technological advancements. Accurate detection of genetic alterations and
biomarkers is made possible by advances in cancer genomics and next-generation
sequencing technologies. A move toward customized medicine will increase the
effectiveness of cancer therapy and decrease side effects by customizing
medicines to each patient's genetic profile.
The market is growing at a substantial rate thanks to
favorable regulatory regulations and expedited approvals for novel treatments
and diagnostics. The growing incidence of cancer worldwide, the increase in
breast cancer cases, and uterine fibrosis are the main factors propelling the
market's expansion. Another important driver of the precision oncology industry is
the rising need for customized medications. The growing use of AI in precision
medicine is also gaining traction and substantially propelling industry
expansion.
Segmentation
Type
· Breast
Cancer
· Prostate
Cancer
· Stomach
Cancer
· Liver
Cancer
· Mouth
Cancer
· Skin
Cancer
· Others
By Products Type
· Therapeutics
· Diagnostics
By End-User
· Hospitals
· Diagnostic
Centers
· Research
and Academic Institutes
· Others
Regional Outlook
· Asia
Pacific
· North
America
· Latin
America
· Europe
· Middle
East and Africa
Key Players
· Thermo
Fisher Scientific Inc.
· Novartis
AG
· Pfizer
Inc.
· Agendria
Inc.
· Rain
Therapeutics Inc.
· Strata
Oncology, Inc.
· F.Hoffman
La Roche Ltd.
· Qiagen
N.V.
· Invitae
Corporation
· Erasca
Inc.
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/precision-oncology-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Comments
Post a Comment